AI Discovers Natural Molecule for Obesity with Promising Side Effect Profile
AI-guided discovery of the natural molecule BRP offers a novel, potentially better-tolerated approach to obesity treatment than existing medications. BRP represents a potential 'Ozempic-like' treatment for obesity that may circumvent common digestive side effects and muscle loss often associated with current GLP-1 agonists.
Animal & Preclinical Data
Demonstrated in living animal models before large-scale human safety and dosing trials begin.